NasdaqGS - Delayed Quote USD

Azenta, Inc. (AZTA)

50.87 -0.47 (-0.92%)
At close: May 17 at 4:00 PM EDT
50.87 0.00 (0.00%)
After hours: May 17 at 4:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
651,756.00
665,072.00
555,498.00
513,703.00
388,537.00
Cost of Revenue
390,820.00
401,932.00
299,914.00
269,894.00
216,389.00
Gross Profit
260,936.00
263,140.00
255,584.00
243,809.00
172,148.00
Operating Expense
342,381.00
350,238.00
279,007.00
274,513.00
208,074.00
Operating Income
-81,445.00
-87,098.00
-23,423.00
-30,704.00
-35,926.00
Net Non Operating Interest Income Expense
42,322.00
43,735.00
15,697.00
-1,405.00
-2,095.00
Other Income Expense
-123,238.00
12,930.00
-2,210.00
-16,860.00
-2,271.00
Pretax Income
-162,361.00
-30,433.00
-9,936.00
-48,969.00
-40,292.00
Tax Provision
-10,100.00
-17,550.00
1,350.00
-20,100.00
-13,930.00
Net Income Common Stockholders
-150,699.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
Diluted NI Available to Com Stockholders
-150,699.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
Basic EPS
-2.71
-0.22
28.48
1.49
0.88
Diluted EPS
-2.71
-0.22
28.48
1.49
0.88
Basic Average Shares
58,863.00
66,253.00
74,897.00
74,229.00
73,557.00
Diluted Average Shares
58,863.00
66,253.00
74,897.00
74,455.00
73,850.00
Total Operating Income as Reported
-206,096.00
-73,126.00
-24,735.00
-31,089.00
-36,600.00
Total Expenses
733,201.00
752,170.00
578,921.00
544,407.00
424,463.00
Net Income from Continuing & Discontinued Operation
-150,699.00
-14,257.00
2,132,859.00
110,747.00
64,853.00
Normalized Income
-35,364.17
-23,920.88
-9,750.24
-28,587.95
-25,921.02
Interest Income
42,322.00
43,735.00
20,286.00
632.00
849.00
Interest Expense
--
--
4,589.00
2,037.00
2,944.00
Net Interest Income
42,322.00
43,735.00
15,697.00
-1,405.00
-2,095.00
EBIT
-24,780.00
-30,433.00
-5,347.00
-46,932.00
-37,348.00
EBITDA
62,878.00
55,151.00
48,355.00
18,401.00
28,148.00
Reconciled Cost of Revenue
390,820.00
401,932.00
299,914.00
269,894.00
216,389.00
Reconciled Depreciation
87,658.00
85,584.00
53,702.00
65,333.00
65,496.00
Net Income from Continuing Operation Net Minority Interest
-152,261.00
-12,883.00
-11,286.00
-28,869.00
-26,362.00
Total Unusual Items Excluding Goodwill
-124,651.00
13,972.00
-1,944.00
-385.00
-674.00
Total Unusual Items
-124,651.00
13,972.00
-1,944.00
-385.00
-674.00
Normalized EBITDA
187,529.00
41,179.00
50,299.00
18,786.00
28,822.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-7,754.17
2,934.12
-408.24
-103.95
-233.02
9/30/2020 - 2/2/1995

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANIK Anika Therapeutics, Inc.
25.40
-0.39%
 
ATRI Atrion Corporation
465.25
+2.06%
 
TECN.SW Tecan Group AG
333.20
-2.91%
 
ANGO AngioDynamics, Inc.
6.04
-5.92%
 
CTEC.L ConvaTec Group PLC
254.60
-0.31%
 
HBIO Harvard Bioscience, Inc.
3.3700
-2.03%
 
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
 
HAZ.DU Haemonetics Corp
86.00
+1.18%
 
CBH.DU Coloplast A/S
11.30
+0.89%
 
ADDLF AddLife AB (publ)
7.94
-77.50%